SEC Form 5 · accession 0001209191-15-014696
CLEVELAND BIOLABS INC · CBLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randy S. Saluck
Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001318641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.80 | Jun 11, 2014 | A | 1,750 | A | Jun 11, 2014 | Jun 11, 2024 | Common Stock | 1,750 | 1,750 | D |
Explanation of responses
- F1As adjusted for 20-to-1 reverse stock split, effective January 28, 2015.